BCAT1 and glioblastoma: In summary, increased expression of BCAT1 in glioblastoma cells with preexisting high levels of expression leads to a decrease in α-KG concentration, stabilization of HIF-1α, and increased cell proliferation and invasion mediated by HIF-1α-dependent expression of FOXM1.